<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04937478</url>
  </required_header>
  <id_info>
    <org_study_id>CTR006 DELAGE 2</org_study_id>
    <nct_id>NCT04937478</nct_id>
  </id_info>
  <brief_title>Correlation of Ultrafiltered Volume (UFV) to Bioimpedance Changes</brief_title>
  <acronym>CTR006</acronym>
  <official_title>Correlation of Ultrafiltered Volume (UFV) During Hemodialysis With a New Battery Powered, Body Worn Electronic Patch Measuring Bioimpedance.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mode Sensors AS</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>HMN Sykehuset Levanger, Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mode Sensors AS</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patient submitted to hemodialysis are followed through a dialysis - interim - dialysis cycle.&#xD;
&#xD;
      No intervention is done. Additional blood tests and clinical tests are used as&#xD;
      pseudo-endpoints. Correlation is made to ultrafiltrated volume (UFV).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 20, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Actual">June 20, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation between ultrafiltered volume (UFV) and measured bioimpedance change</measure>
    <time_frame>During hemodialysis</time_frame>
    <description>A change in measured thoracic bioimpedance is expected to correlate to UFV</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hemodialysis, Ultrafiltration, Bioimpedance</condition>
  <arm_group>
    <arm_group_label>Hemodialysis patients</arm_group_label>
    <description>Patients who undergo hemodialysis in hospital every two oe three days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observation</intervention_name>
    <description>Only observational study, no intervention.</description>
    <arm_group_label>Hemodialysis patients</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum:&#xD;
&#xD;
        -  osmolality&#xD;
&#xD;
        -  hemoglobin&#xD;
&#xD;
        -  platelets&#xD;
&#xD;
        -  sodium&#xD;
&#xD;
        -  potassium&#xD;
&#xD;
        -  creatinine&#xD;
&#xD;
        -  urea&#xD;
&#xD;
        -  glucose&#xD;
&#xD;
        -  magnesium&#xD;
&#xD;
        -  albumin&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated with hemodialysis for survival.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients scheduled for hemodialysis&#xD;
&#xD;
          -  signed Informed Consent Form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  acute intercurrent disease,&#xD;
&#xD;
          -  subjects with known hypersensitivity to plasters (adhesive or gel).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ellen AA Jaatun, MD PhD</last_name>
    <phone>+4747758889</phone>
    <email>ellen.jaatun@modesensors.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jorn Kvaerness, C.R</last_name>
    <phone>+4795089723</phone>
    <email>jorn@modesensors.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Levanger Hospital</name>
      <address>
        <city>Levanger</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carl Platou</last_name>
      <email>carl.platou@helse-nordtrondelag.no</email>
    </contact>
    <investigator>
      <last_name>Solfrid Romundstad</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Olavs university hospital</name>
      <address>
        <city>Trondheim</city>
        <zip>7030</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inger K Lægreid, MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>Cecilia MM Øien, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 16, 2021</study_first_submitted>
  <study_first_submitted_qc>June 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 24, 2021</study_first_posted>
  <last_update_submitted>November 11, 2021</last_update_submitted>
  <last_update_submitted_qc>November 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual participant data will not be shared</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

